Quick Takeaways
- Sofinnova Crossover I filed SCHEDULE 13D/A for Abivax SA Ordinary Shares, par value (euro)0.01 per share (ABVX).
- Disclosed ownership: 9.4%.
- Date of event: 28 Oct 2025.
Quoteable Key Fact
"Sofinnova Crossover I disclosed 9.4% ownership in Abivax SA Ordinary Shares, par value (euro)0.01 per share (ABVX) on 28 Oct 2025."
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original Filing| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Sofinnova Crossover I SLP | 9.4% | 8,399,478 | 8,399,478 | 0 | /s/ Antoine Papiernik | Managing Partner | 0001845105 |
| Sofinnova Partners SAS | 9.4% | 8,399,478 | 8,399,478 | 0 | /s/ Antoine Papiernik | Managing Partner | 0001574139 |
| Antoine Papiernik | 9.4% | 8,399,478 | 8,399,478 | 0 | /s/ Antoine Papiernik | Antoine Papiernik | 0001768408 |
| Cedric Moreau | 9.4% | 8,399,478 | 8,399,478 | 0 | /s/ Cedric Moreau | Cedric Moreau | |
| Kinam Hong | 9.4% | 8,399,478 | 8,399,478 | 0 | /s/ Kinam Hong | Kinam Hong | |
| Joseph Anderson | 9.4% | 8,399,478 | 8,399,478 | 0 | /s/ Joseph Anderson | Joseph Anderson | |
| Jacques Theurillat | 9.4% | 8,399,478 | 8,399,478 | 0 | /s/ Jacques Theurillat | Jacques Theurillat |